TEXTOTEX P - Testosterone Propionate

Key Benefits of TEXTOTEX P: Ultra-fast action: Testosterone propionate is the shortest-acting ester, with peak plasma concentration reached within 24-48 hours after injection . Anabolic effects manifest within hours, providing an immediate response to administration. Precise hormonal control: Its short half-life allows for rapid dose adjustments and greater ability to respond to changes in individual response. This makes it the preferred choice for athletes needing fine control over their protocol. Higher peak release: Propionate produces faster release and higher serum peaks than other esters, resulting in greater immediate anabolic stimulation . This is especially valuable in the initial phase of a cycle or competition preparation. Favorable safety profile: The short half-life means testosterone levels return to normal more quickly after discontinuation, reducing the period of hormonal suppression and facilitating faster post-cycle recovery. Less water retention: Compared to longer-acting esters, propionate tends to produce less water retention, favoring a drier and more defined appearance. Less aromatization: Although all testosterone esters aromatize, the shorter exposure to elevated testosterone levels can result in lower total conversion to estradiol. Improved physical performance: Studies in animal models demonstrate that testosterone propionate significantly improves muscle strength, endurance, and volume in short-term applications through activation of the IGF-1/AKT pathway . Administration versatility: Its short action allows for daily or every-other-day administration, maintaining stable levels and avoiding sharp hormonal fluctuations.

How does TEXTOTEX P work? Textotex P contains Testosterone Propionate USP, the shortest-acting testosterone ester . Unlike other esters like cypionate or enanthate, propionate is designed for fast action and precise control. Protein synthesis: Testosterone binds to the androgen receptor, activating signaling pathways that promote protein synthesis and nitrogen retention . Propionate, releasing testosterone more rapidly, produces a more pronounced anabolic peak. IGF-1/AKT Pathway: Studies in animal models demonstrate that testosterone propionate activates the IGF-1/AKT pathway, increasing IGF-1 levels, phosphorylated AKT, and mTOR, resulting in increased protein synthesis and decreased protein degradation . This explains its potent effect in improving muscle strength, endurance, and volume . Propionate pharmacokinetics: Testosterone propionate is the shortest-acting ester, with a half-life of approximately 4.5 days . Peak plasma concentration is reached within 24-48 hours after injection . Partial aromatization: Testosterone is partially aromatized to estradiol, an important process for normal physiological function, but which may require management with aromatase inhibitors at elevated doses. Conversion to DHT: Testosterone is converted to dihydrotestosterone (DHT) by the 5-alpha reductase enzyme, mediating androgenic effects in sensitive tissues such as the prostate and scalp. Metabolite profile: A comparative study of testosterone esters showed that propionate users had significantly higher follicle-stimulating hormone (FSH) levels compared to enanthate users, suggesting less severe HPG axis suppression with propionate . Unique pharmacokinetics: Due to its short duration of action, administration on alternating days is recommended to maintain stable levels. This characteristic makes it the ester of choice for protocols requiring precise control.

Usage Guide for TEXTOTEX P: Administration route: Deep and slow intramuscular injection, preferably in the glute (upper outer quadrant) or deltoid. Should not be administered intravenously. Frequency: Due to its short half-life (4.5 days) and fast action, administration is recommended every 1-3 days (preferably every other day or daily) to maintain stable plasma levels and avoid hormonal fluctuations. Recommended dosage for men: 50 to 100 mg every 1-2 days (0.5 to 1 mL of TEXTOTEX P). Typical daily doses range from 50-150 mg per day, depending on the protocol and user experience. Typical cycles of 6 to 10 weeks. Recommended dosage for women: Testosterone use in women is not recommended due to high risk of virilization. Recommended cycle: Ideal for advanced cutting protocols, competition preparation, and short cycles where precise control is required. Excellent for 6-8 week cycles. Stacking: Frequently combined with other compounds such as nandrolone, boldenone, trenbolone, or oral compounds. Its fast action makes it ideal for initial phases of cycles or as a base in competition preparation. Post-cycle therapy (PCT): PCT should be started approximately 2-3 days after the last injection due to the compound's short half-life, facilitating faster HPG axis recovery. Precautions and monitoring: Periodic monitoring of lipid profile, liver function, blood pressure, and hematocrit levels is recommended during the cycle. Long-term use may suppress endogenous testosterone production and affect fertility. Anti-doping warning: Testosterone and all its esters, including propionate, are included in the WADA 2025-2026 Prohibited List as S1.1 Anabolic Androgenic Steroids, prohibited at all times (in and out of competition). WADA has clarified that esters of prohibited anabolic agents are also prohibited . Testosterone propionate is detectable in dried blood spots (DBS) for up to 97 hours after application .

Composition of TEXTOTEX P: Active Ingredient: Testosterone Propionate USP 100 mg per mL. High-purity compound with USP pharmaceutical grade. Chemical name: 17β-hydroxyandrost-4-en-3-one propionate. Molecular formula: C₂₂H₃₂O₃. Vehicle: Pharmaceutical-grade sesame oil (Sesamum indicum), selected for its low viscosity and excellent tolerance profile. Preservative: Benzyl alcohol (1-2%) as a bacteriostatic agent, ensuring product stability and sterility. Presentation: 1 mL ampoules with 100 mg/mL concentration (10 ampoules per box). Total of 100 mg of Testosterone Propionate per ampoule. Appearance: Clear pale yellow oily solution. Classification: Schedule III controlled substance in the United States. Certification: Manufactured under USP (United States Pharmacopeia) and GMP (Good Manufacturing Practices) standards. Quality control: Purity and potency testing performed by certified independent laboratories using high-performance liquid chromatography (HPLC) and mass spectrometry. Purity: >98% purity, guaranteeing maximum quality and consistency in each batch. Storage: Store at controlled room temperature 20°-25°C (68°-77°F), in a dry place protected from light. Do not freeze.

Onset time and expected results: Onset time: Anabolic effects begin within hours after injection, with peak concentration reached in 24-48 hours . This is the fastest response among all testosterone esters. Results at 1-2 weeks: Rapid strength increase, improved recovery, increased libido, and sense of well-being. The response is more immediate than with other esters. Results at 2-4 weeks: Significant improvement in body composition, lean muscle mass gain, and body fat reduction. Effects manifest more quickly than with other esters. Results at 4-6 weeks: Notable muscle growth, sustained strength increase, and improved physical performance. Ideal for short preparation cycles. Results at 6-8 weeks: Optimal results with quality muscle mass gains and increased strength. With a shorter cycle, post-cycle recovery is faster. Expected results (6-8 week cycle at 50-100 mg daily or every other day): Lean muscle mass: Significant increase in short period Strength increase in compound exercises: +10-15% Body fat reduction: Notable in short period Water retention: Minimal to moderate (less than enanthate/cypionate) Post-cycle recovery: Faster due to short half-life

Clinical research and laboratory testing: Animal model studies: Recent research (2020) in rat models with sepsis demonstrated that short-term testosterone propionate significantly improved maximum contraction force, fatigue index, and average cross-sectional area of muscle fibers. The study demonstrated that propionate activates the IGF-1/AKT pathway, increasing IGF-1, phosphorylated AKT, and mTOR levels, resulting in increased protein synthesis and decreased protein degradation . The study also demonstrated that short-duration propionate did not cause testicular atrophy or prostate hyperplasia in septic rats . Metabolite profile: A comparative study of testosterone esters showed that propionate users had higher FSH levels than enanthate users, suggesting less severe HPG axis suppression and a more favorable recovery profile . Anti-doping detection: 2025 research on dried blood spot (DBS) analysis of testosterone propionate demonstrated that propionate is detectable for up to 97 hours after application, with confirmed identification up to 49 hours . The stability of testosterone esters in dried blood allows for direct detection without derivatization . The study also warns about contamination risk in finger-prick samples . Historical clinical studies: Testosterone propionate is one of the oldest and most studied esters. It was developed in the 1930s and has been used in countless clinical studies on the effects of testosterone on muscle mass, strength, and physical function. While its therapeutic use has declined with the emergence of longer-acting esters, it remains in use for its rapid action and precise control . Safety profile: The short half-life of propionate results in a favorable safety profile in terms of HPG axis recovery. However, abuse of anabolic steroids can lead to serious health risks, including cardiovascular, hepatic, and psychiatric effects . 3rd party testing: Our batches are subjected to purity and potency testing by certified independent laboratories using: High-performance liquid chromatography (HPLC) for purity Mass spectrometry for molecular identification Sterility and bacterial endotoxin testing Certifications: Manufactured under GMP (Good Manufacturing Practices) standards USP quality control (United States Pharmacopeia) Stability and shelf-life testing (24 months) Heavy metals and contaminant analysis Anti-doping warning: Testosterone and all its esters, including propionate, are included in the WADA 2025-2026 Prohibited List as S1.1 Anabolic Androgenic Steroids, prohibited at all times (in and out of competition). WADA has clarified that esters of prohibited anabolic agents are also prohibited .